Anamika Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anamika Patel has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Avinash Pathengay
Department of Vitreoretina and Uveitis Services, L V Prasad Eye Institute, GMRV Campus, Visakhapatnam, Andhra Pradesh, India
12 shared publicationsIlaria Testi
Uveitis Department, Moorfields Eye Hospital, London, UK
9 shared publicationsAnup Kelgaonkar
Department of Vitreoretina and Uveitis Services, L V Prasad Eye Institute, MTC Campus, Bhubaneshwar, Odisha, India
8 shared publicationsCarlos Pavesio
Uveitis Department, Moorfields Eye Hospital, London, UK
7 shared publications- Alessandro Feo
Department of Biomedical Sciences, Humanitas University, Milan, Italy
4 shared publications Harry Petrushkin
Uveitis Department, Moorfields Eye Hospital, 162 City Rd, London, EC1V 2PD, UK
3 shared publications
Latest Publications
- 30 October 2026
- Published by Elsevier in Canadian Journal of Ophthalmology
Steroid-induced macular edema in peripapillary pachychoroid syndrome
- 30 October 2026
- Published by Elsevier in Canadian Journal of Ophthalmology
Steroid-induced macular edema in peripapillary pachychoroid syndrome
- 12 October 2026
- Published by Wolters Kluwer Health in Retina
LAMELLAR MACULAR HOLE AFTER ACQUIRED VITELLIFORM LESION COLLAPSE IN INTERMEDIATE AGE-RELATED MACULAR DEGENERATION
Was not provided for this article.
- 12 October 2026
- Published by Wolters Kluwer Health in Retina
LAMELLAR MACULAR HOLE AFTER ACQUIRED VITELLIFORM LESION COLLAPSE IN INTERMEDIATE AGE-RELATED MACULAR DEGENERATION
Was not provided for this article.
- 6 October 2026
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- p. 1-7
Choroidal Tuberculosis in Miliary Disease: A Multimodal Imaging Spectrum Across Iatrogenic and Disease-Mediated Immunosuppression
Tuberculosis (TB) remains a leading infectious cause worldwide, with choroidal involvement the most common posterior segment manifestation of miliary disease, due to haematogenous uveal seeding.1,2...
- 6 October 2026
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- p. 1-7
Choroidal Tuberculosis in Miliary Disease: A Multimodal Imaging Spectrum Across Iatrogenic and Disease-Mediated Immunosuppression
Tuberculosis (TB) remains a leading infectious cause worldwide, with choroidal involvement the most common posterior segment manifestation of miliary disease, due to haematogenous uveal seeding.1,2...
- 30 July 2026
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 61 (6) , 1610-1613
Cuticular drusen: a case report with 20-year follow up
- 30 July 2026
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 61 (6) , 1610-1613
Cuticular drusen: a case report with 20-year follow up
- 29 July 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 291, 292-300
Internal Limiting Membrane Loop Configurations in Epiretinal Membrane: Prevalence, Imaging Associations and Optical Coherence Tomography Morphology
- 29 July 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 291, 292-300
Internal Limiting Membrane Loop Configurations in Epiretinal Membrane: Prevalence, Imaging Associations and Optical Coherence Tomography Morphology
- Open Access
- 24 June 2026
- Published by Springer Nature in Journal of Ophthalmic Inflammation and Infection
- Vol. 16 (1)
Delayed-onset cytomegalovirus retinitis after 0.2 µg/day fluocinolone acetonide implantation: a case series
Purpose: To describe the clinical features and outcomes of cytomegalovirus retinitis (CMVR) presenting after intravitreal fluocinolone acetonide (FAc) implantation. Methods: Single centre, retrospective observational case series involving three patients who developed CMVR several months after FAc implantation at the uveitis department at Moorfields Eye Hospital, London, UK. Clinical history, immune status, ocular findings, imaging, and management were reviewed. Results: The first patient with pulmonary sarcoidosis and no systemic treatment presented 14 months post-implant with granular retinitis and severe occlusive retinal vasculitis. He developed renal toxicity to valganciclovir, necessitating intravitreal foscarnet and FAc implant removal. The second patient with presumed ocular sarcoidosis on multiple immunosuppressive agents developed fulminant necrotising CMVR eight months after FAc implantation and responded well to systemic valganciclovir with adjunctive intravitreal foscarnet therapy. The third patient, an elderly man with previous CMV retinitis in the context of follicular lymphoma, experienced reactivation at the margin of an old scar several months after FAc implantation and was stabilised with intravenous and intravitreal foscarnet. Although two patients had bilateral implants, the retinitis remained unilateral. Across cases, presentations ranged from granular retinitis with vasculitis to fulminant necrosis and late reactivation. Conclusion: Delayed-onset CMVR can occur in eyes treated with FAc implants, particularly in immunosuppressed patients. Recognition of atypical presentations, early PCR testing and timely antiviral therapy are essential to preserve vision.
- 24 June 2026
- Published by Springer Nature in Journal of Ophthalmic Inflammation and Infection
- Vol. 16 (1)
Open AccessDelayed-onset cytomegalovirus retinitis after 0.2 µg/day fluocinolone acetonide implantation: a case series
Purpose: To describe the clinical features and outcomes of cytomegalovirus retinitis (CMVR) presenting after intravitreal fluocinolone acetonide (FAc) implantation. Methods: Single centre, retrospective observational case series involving three patients who developed CMVR several months after FAc implantation at the uveitis department at Moorfields Eye Hospital, London, UK. Clinical history, immune status, ocular findings, imaging, and management were reviewed. Results: The first patient with pulmonary sarcoidosis and no systemic treatment presented 14 months post-implant with granular retinitis and severe occlusive retinal vasculitis. He developed renal toxicity to valganciclovir, necessitating intravitreal foscarnet and FAc implant removal. The second patient with presumed ocular sarcoidosis on multiple immunosuppressive agents developed fulminant necrotising CMVR eight months after FAc implantation and responded well to systemic valganciclovir with adjunctive intravitreal foscarnet therapy. The third patient, an elderly man with previous CMV retinitis in the context of follicular lymphoma, experienced reactivation at the margin of an old scar several months after FAc implantation and was stabilised with intravenous and intravitreal foscarnet. Although two patients had bilateral implants, the retinitis remained unilateral. Across cases, presentations ranged from granular retinitis with vasculitis to fulminant necrosis and late reactivation. Conclusion: Delayed-onset CMVR can occur in eyes treated with FAc implants, particularly in immunosuppressed patients. Recognition of atypical presentations, early PCR testing and timely antiviral therapy are essential to preserve vision.
- Open Access
- 23 June 2026
- Published by Springer Nature in Journal of Ophthalmic Inflammation and Infection
- Vol. 16 (1)
Occlusive retinal vasculopathy on ultrawide-field fluorescein angiography in intraocular cytomegalovirus infection: a case series
Purpose: To describe ultrawide-field fluorescein angiographic features of extensive retinal capillary non-perfusion in eyes with intraocular cytomegalovirus infection. Methods: Retrospective, single-centre observational study. Results: Five patients (six eyes) with intraocular CMV infection were included (mean age 62 years; range 15–84). All eyes showed widespread retinal haemorrhages without features of classical oedematous/haemorrhagic necrotising cytomegalovirus retinitis. In eyes with retinitis, the lesions showed a granular phenotype.Three eyes presented with hypertensive uveitis and raised intraocular pressure without neovascularisation. Ultrawide-field fluorescein angiography demonstrated extensive capillary non-perfusion involving both arterioles and venules, reflecting a predominantly occlusive vasculopathy. Vitreous haemorrhage occurred in three eyes, and one progressed to phthisis bulbi despite virological control. Predisposing factors included haematological malignancy, severe malnutrition, local corticosteroid implantation, diabetes with preceding shingles, and systemic immunomodulatory therapy. All the patients received systemic and intravitreal anti viral treatment and were additionally treated for the raised intraocular pressure and respective complications secondary to retinal ischemia. Conclusion: Intraocular cytomegalovirus infection in non-human-immunodeficiency-virus patients may present as hypertensive uveitis with an occlusive pan-retinal vasculopathy, with or without retinitis, best recognised on ultrawide-field fluorescein angiography. Antiviral therapy and laser may achieve initial control but are insufficient alone; long-term monitoring and patient counselling are essential to address recurrent haemorrhage and neovascular glaucoma.
- 23 June 2026
- Published by Springer Nature in Journal of Ophthalmic Inflammation and Infection
- Vol. 16 (1)
Open AccessOcclusive retinal vasculopathy on ultrawide-field fluorescein angiography in intraocular cytomegalovirus infection: a case series
Purpose: To describe ultrawide-field fluorescein angiographic features of extensive retinal capillary non-perfusion in eyes with intraocular cytomegalovirus infection. Methods: Retrospective, single-centre observational study. Results: Five patients (six eyes) with intraocular CMV infection were included (mean age 62 years; range 15–84). All eyes showed widespread retinal haemorrhages without features of classical oedematous/haemorrhagic necrotising cytomegalovirus retinitis. In eyes with retinitis, the lesions showed a granular phenotype.Three eyes presented with hypertensive uveitis and raised intraocular pressure without neovascularisation. Ultrawide-field fluorescein angiography demonstrated extensive capillary non-perfusion involving both arterioles and venules, reflecting a predominantly occlusive vasculopathy. Vitreous haemorrhage occurred in three eyes, and one progressed to phthisis bulbi despite virological control. Predisposing factors included haematological malignancy, severe malnutrition, local corticosteroid implantation, diabetes with preceding shingles, and systemic immunomodulatory therapy. All the patients received systemic and intravitreal anti viral treatment and were additionally treated for the raised intraocular pressure and respective complications secondary to retinal ischemia. Conclusion: Intraocular cytomegalovirus infection in non-human-immunodeficiency-virus patients may present as hypertensive uveitis with an occlusive pan-retinal vasculopathy, with or without retinitis, best recognised on ultrawide-field fluorescein angiography. Antiviral therapy and laser may achieve initial control but are insufficient alone; long-term monitoring and patient counselling are essential to address recurrent haemorrhage and neovascular glaucoma.
- Open Access
- 4 May 2026
- Published by Elsevier in Ophthalmology Retina
- Vol. 10 (8) , 863-873
Pediatric Uveitic Macular Edema in Noninfectious Uveitis
- 4 May 2026
- Published by Elsevier in Ophthalmology Retina
- Vol. 10 (8) , 863-873
Open AccessPediatric Uveitic Macular Edema in Noninfectious Uveitis
- 28 January 2026
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 26 (2) , e130-e131
Paediatric ocular toxocariasis with relentless progression despite negative metagenomic testing
- 28 January 2026
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 26 (2) , e130-e131
Paediatric ocular toxocariasis with relentless progression despite negative metagenomic testing
- 6 January 2026
- Published by BMJ in British Journal of Ophthalmology
- Vol. 110 (7) , 802-804
Intravitreal dexamethasone implant for refractory stromal choroiditis in birdshot retinochoroiditis: efficacy and therapeutic implications
This retrospective, single-centre observational study evaluated the efficacy of intravitreal dexamethasone implant in the management of stromal choroiditis in Birdshot retinochoroiditis refractory to systemic immunosuppression. Four patients with bilateral stromal choroiditis unresponsive to systemic treatment received bilateral dexamethasone implant. Therapeutic response was assessed using indocyanine green angiography, demonstrating resolution of hypofluorescent dots, corresponding to active stromal choroidal lesions, in all cases. While intravitreal dexamethasone is not recommended as monotherapy for this chronic condition requiring long-term systemic immunosuppression, it proved to be effective in cases of refractory stromal involvement, particularly when systemic corticosteroids are contraindicated or during periods of therapeutic transition.
- 6 January 2026
- Published by BMJ in British Journal of Ophthalmology
- Vol. 110 (7) , 802-804
Intravitreal dexamethasone implant for refractory stromal choroiditis in birdshot retinochoroiditis: efficacy and therapeutic implications
This retrospective, single-centre observational study evaluated the efficacy of intravitreal dexamethasone implant in the management of stromal choroiditis in Birdshot retinochoroiditis refractory to systemic immunosuppression. Four patients with bilateral stromal choroiditis unresponsive to systemic treatment received bilateral dexamethasone implant. Therapeutic response was assessed using indocyanine green angiography, demonstrating resolution of hypofluorescent dots, corresponding to active stromal choroidal lesions, in all cases. While intravitreal dexamethasone is not recommended as monotherapy for this chronic condition requiring long-term systemic immunosuppression, it proved to be effective in cases of refractory stromal involvement, particularly when systemic corticosteroids are contraindicated or during periods of therapeutic transition.